CME Group Inc.
CME Financial Financial Data & Stock Exchanges
CME Group Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.5 billion, up 6.37% from fiscal 2024.
- Revenue
- +13.0%
- EPS
- +16.5%
- Free cash flow
- +12.7%
- Total debt
- +0.11%
Quarter to September 2026, against a year earlier
Follow CME
Alert me
CME Group Inc. (CME) P/E ratio
As of 5 November 2026, CME Group Inc. (CME) trades at a P/E ratio of 25.0×. Over the past ten years it has ranged from 12.1× (January 2018) to 43.4× (September 2019); the current reading is higher than 37% of that period. That is in line with the Financial Data & Stock Exchanges industry median of 24.9× and above the Financial sector median of 12.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 24.4× | 1.92% |
| FY2024 | 24.0× | 1.60% |
| FY2023 | 23.6× | 3.46% |
| FY2022 | 22.8× | (26.95%) |
| FY2021 | 31.2× | 0.81% |
| FY2020 | 31.0× | (8.68%) |
| FY2019 | 33.9× | 3.45% |
| FY2018 | 32.8× | 171.40% |
| FY2017 | 12.1× | (52.08%) |
| FY2016 | 25.2× | 3.18% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 21.3× | 14.68% |
| Jun 2026 | 18.6× | (25.73%) |
| Mar 2026 | 25.0× | 2.47% |
| Dec 2025 | 24.4× | (6.61%) |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| COIN Coinbase Global, Inc. compare | n/m |
| TRU TransUnion compare | 19.9× |
| ICE Intercontinental Exchange Inc. compare | 23.6× |
| CME CME Group Inc. | 25.0× |
| CBOE Cboe Global Markets, Inc. compare | 25.0× |
| SPGI S&P Global Inc. compare | 27.6× |
| NDAQ Nasdaq, Inc. compare | 28.9× |
| MCO Moody's Corporation compare | 31.3× |
| MSCI MSCI Inc compare | 34.8× |
| Financial Data & Stock Exchanges industry median | 24.9× |
| Financial sector median | 12.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on CME
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- The full statement